SATB1 and pancreatic neoplasm: One group demonstrated that CAF-secreted SDF-1 drives gemcitabine resistance in pancreatic cancer by forming a positive feedback loop that drives paracrine induction of SATB-1 in the pancreatic cancer cells (Wei et al., 2018).